Flow-Mediated Dilation Test Global Market Report 2026

A flow-mediated dilation test is a non-invasive vascular ultrasound examination performed to assess endothelial function by measuring the percentage increase in the diameter of the brachial artery after a temporary period of ischemia created using a blood pressure cuff. This diagnostic procedure evaluates the ability of the endothelium to produce nitric oxide in response to increased shear stress and serves as an important early marker for cardiovascular disease and the development of atherosclerosis.

The primary analysis methods of flow-mediated dilation tests include automated flow mediated dilation analysis, semi automated flow mediated dilation analysis, and manual flow mediated dilation analysis. Automated flow mediated dilation analysis refers to computer-assisted measurement systems that automatically assess changes in arterial diameter following temporary blood flow occlusion to evaluate endothelial function and vascular health. These methods are used for cardiovascular risk assessment, metabolic disorder evaluation, and research and clinical trials, serving hospitals, diagnostic centers, cardiology clinics, research institutes and academic centers, and ambulatory surgical centers.

Tariffs are influencing the flow-mediated dilation test market by increasing the cost of imported ultrasound systems, vascular imaging technologies, and specialized diagnostic equipment required for endothelial function evaluation. This is limiting the adoption of advanced flow-mediated dilation solutions, particularly in regions dependent on imported medical devices such as North America, Europe, and Asia-Pacific. Equipment-intensive segments, including automated flow-mediated dilation analysis systems and artificial intelligence-based vessel tracking solutions, are experiencing the greatest impact because of their reliance on imported hardware and software technologies. However, tariffs are also promoting domestic manufacturing, expanding regional supply chain diversification, and encouraging increased investment in local medical imaging technologies, supporting long-term market stability.

The flow-mediated dilation test market research report is one of a series of new reports from The Business Research Company that provides flow-mediated dilation test market statistics, including flow-mediated dilation test industry global market size, regional shares, competitors with a flow-mediated dilation test market share, detailed flow-mediated dilation test market segments, market trends and opportunities, and any further data you may need to thrive in the flow-mediated dilation test industry. This flow-mediated dilation test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The flow-mediated dilation test market size has grown strongly in recent years. It will grow from $0.07 billion in 2025 to $0.08 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases and atherosclerosis, rising awareness about early cardiovascular risk assessment, growing demand for non-invasive diagnostic procedures, increasing adoption of vascular health monitoring in clinical research, rising utilization of ultrasound-based endothelial function evaluation.

The flow-mediated dilation test market size is expected to see strong growth in the next few years. It will grow to $0.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing adoption of AI-based vessel measurement solutions, growing demand for personalized cardiovascular risk prediction, rising integration of advanced imaging software with diagnostic systems, increasing expansion of preventive healthcare screening programs, growing clinical adoption of automated endothelial assessment technologies. Major trends in the forecast period include increasing adoption of automated flow-mediated dilation analysis for faster endothelial function assessment, growing integration of advanced ultrasound imaging technologies for improved vascular measurement accuracy, rising demand for non-invasive cardiovascular disease risk evaluation methods, increasing use of endothelial function testing for early detection of vascular abnormalities, growing adoption of standardized clinical protocols for flow-mediated dilation testing.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the flow-mediated dilation test market going forward. Cardiovascular diseases refer to a group of disorders that affect the heart and blood vessels, including coronary artery disease, stroke, heart failure, and peripheral arterial disease. The prevalence of cardiovascular diseases is increasing due to the growing occurrence of lifestyle-related risk factors such as obesity, diabetes, hypertension, physical inactivity, and unhealthy dietary patterns. The flow-mediated dilation test market supports cardiovascular disease management by facilitating the early detection of endothelial dysfunction, enabling healthcare providers to identify cardiovascular risks before the development of structural vascular damage and supporting timely preventive interventions. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, cardiovascular disease resulted in 919,032 deaths in 2023, representing approximately one in every three deaths. Therefore, the rising prevalence of cardiovascular diseases is contributing to the growth of the flow-mediated dilation test market.

The growing incidence of diabetes and obesity is expected to drive the growth of the flow-mediated dilation test market going forward. Diabetes and obesity are chronic metabolic conditions in which diabetes is characterized by consistently elevated blood glucose levels, while obesity involves excessive accumulation of body fat that increases the risk of cardiovascular disease, hypertension, and other long-term health complications. The incidence of diabetes and obesity is increasing due to sedentary lifestyles that have decreased physical activity levels and heightened the risk of metabolic disorders. The flow-mediated dilation test supports the management of diabetes and obesity by enabling early evaluation of endothelial dysfunction, detecting cardiovascular risks before the progression of clinical disease, and assisting clinicians in monitoring vascular health throughout treatment. For instance, in February 2026, according to the National Diabetes Audit (NDA) 2024-25 published by the Government of the United Kingdom, a UK-based government department, 43.0% of individuals with type 1 diabetes in England received all eight recommended care processes during the financial year ending March 2025. Therefore, the growing incidence of diabetes and obesity is contributing to the growth of the flow-mediated dilation test market.

The increasing incidence of comorbidities is expected to drive the growth of the flow-mediated dilation test market going forward. Comorbidities refer to the occurrence of two or more chronic health conditions, including diabetes, hypertension, obesity, and chronic kidney disease, within the same individual. The incidence of comorbidities is increasing due to aging populations, sedentary lifestyles, and the rising burden of chronic diseases. Flow-mediated dilation tests support the management of patients with multiple comorbid conditions by enabling early assessment of endothelial dysfunction, identifying increased cardiovascular risk, and assisting clinicians in monitoring vascular health before the occurrence of major cardiovascular events. For instance, in August 2025, according to the International Journal of Population Data Science (IJPDS), a UK-based scientific journal, the average number of comorbidities was higher among individuals from the most deprived population groups compared with those from the least deprived population groups (1.84 vs. 1.49; p < 0.001). Additionally, 28.6% of people with multiple sclerosis (pwMS) in the most deprived areas had more than three comorbidities, compared with 20.6% of those in the least deprived areas. Therefore, the increasing incidence of comorbidities is contributing to the growth of the flow-mediated dilation test market.

Major companies operating in the flow-mediated dilation test market report are Canon Medical Systems, Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Mindray Medical, D.E. Hokanson Inc, Quipu Srl, Vascular Diagnostics, UNEX Corporation.

North America was the dominant region in the flow-mediated dilation test market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the flow-mediated dilation test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the flow-mediated dilation test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The flow-mediated dilation test market consists of revenues earned by entities by providing services such as flow-mediated dilation (FMD) testing services, endothelial function assessment services, vascular ultrasound imaging services, cardiovascular risk assessment services, diagnostic reporting and interpretation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Flow-Mediated Dilation Test Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses flow-mediated dilation test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for flow-mediated dilation test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The flow-mediated dilation test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Analysis Method: Automated Flow Mediated Dilation Analysis; Semi Automated Flow Mediated Dilation Analysis; Manual Flow Mediated Dilation Analysis
• 2) By Application: Cardiovascular Risk Assessment; Metabolic Disorder Evaluation; Research And Clinical Trials
• 3) By End User: Hospitals; Diagnostic Centers; Cardiology Clinics; Research Institutes And Academic Centers; Ambulatory Surgical Centers
• Subsegments:
• 1) By Automated Flow Mediated Dilation Analysis: Real Time Automated Edge Detection; Artificial Intelligence Based Vessel Wall Tracking; Fully Automated Diameter Measurement; Automated Endothelial Function Assessment
• 2) By Semi Automated Flow Mediated Dilation Analysis: Operator Assisted Edge Detection; Manual Region Of Interest Selection With Automated Measurement; Software Guided Image Analysis; Hybrid Diameter Measurement
• 3) By Manual Flow Mediated Dilation Analysis: Caliper Based Diameter Measurement; Frame By Frame Ultrasound Analysis; Offline Manual Image Analysis; Visual Vessel Diameter Assessment
• Companies Mentioned: Canon Medical Systems; Siemens Healthineers AG; GE HealthCare; Koninklijke Philips N.V.; Mindray Medical; D.E. Hokanson Inc; Quipu Srl; Vascular Diagnostics; UNEX Corporation.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.